IOL CHEMICALS & PHARM. | CHANDRA BHAGAT PHARMA | IOL CHEMICALS & PHARM./ CHANDRA BHAGAT PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | - | - | View Chart |
P/BV | x | 1.6 | 3.1 | 51.1% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. CHANDRA BHAGAT PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
CHANDRA BHAGAT PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ CHANDRA BHAGAT PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 136 | 394.6% | |
Low | Rs | 272 | 83 | 328.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 158.5 | 238.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | 1.2 | 1,977.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 1.3 | 2,345.4% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 36.4 | 705.6% | |
Shares outstanding (eoy) | m | 58.71 | 7.55 | 777.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.7 | 155.1% | |
Avg P/E ratio | x | 17.1 | 91.2 | 18.7% | |
P/CF ratio (eoy) | x | 12.8 | 81.3 | 15.8% | |
Price / Book Value ratio | x | 1.6 | 3.0 | 52.4% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 826 | 2,873.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 13 | 12,723.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,197 | 1,852.7% | |
Other income | Rs m | 256 | 3 | 8,740.6% | |
Total revenues | Rs m | 22,427 | 1,200 | 1,869.5% | |
Gross profit | Rs m | 2,257 | 32 | 7,101.0% | |
Depreciation | Rs m | 462 | 1 | 41,585.6% | |
Interest | Rs m | 165 | 22 | 749.3% | |
Profit before tax | Rs m | 1,887 | 12 | 16,234.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 3 | 19,264.6% | |
Profit after tax | Rs m | 1,391 | 9 | 15,374.6% | |
Gross profit margin | % | 10.2 | 2.7 | 383.3% | |
Effective tax rate | % | 26.2 | 22.1 | 118.9% | |
Net profit margin | % | 6.3 | 0.8 | 829.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 589 | 1,641.3% | |
Current liabilities | Rs m | 5,025 | 269 | 1,864.8% | |
Net working cap to sales | % | 20.9 | 26.7 | 78.4% | |
Current ratio | x | 1.9 | 2.2 | 88.0% | |
Inventory Days | Days | 43 | 0 | 12,909.5% | |
Debtors Days | Days | 8 | 250 | 3.3% | |
Net fixed assets | Rs m | 11,017 | 7 | 151,337.9% | |
Share capital | Rs m | 587 | 75 | 778.1% | |
"Free" reserves | Rs m | 14,490 | 199 | 7,269.0% | |
Net worth | Rs m | 15,077 | 275 | 5,486.8% | |
Long term debt | Rs m | 0 | 39 | 0.0% | |
Total assets | Rs m | 20,684 | 606 | 3,414.1% | |
Interest coverage | x | 12.5 | 1.5 | 814.7% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 2.0 | 54.3% | |
Return on assets | % | 7.5 | 5.1 | 146.9% | |
Return on equity | % | 9.2 | 3.3 | 280.1% | |
Return on capital | % | 13.6 | 10.7 | 127.2% | |
Exports to sales | % | 26.7 | 48.1 | 55.6% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 576 | 1,029.9% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 576 | 1,029.9% | |
Fx outflow | Rs m | 6,052 | 7 | 86,826.4% | |
Net fx | Rs m | -122 | 569 | -21.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 53 | 2,322.8% | |
From Investments | Rs m | -1,200 | -1 | 203,389.8% | |
From Financial Activity | Rs m | -41 | -44 | 92.4% | |
Net Cashflow | Rs m | -18 | 8 | -242.7% |
Indian Promoters | % | 48.2 | 68.8 | 70.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 2.2 | 76.6% | |
FIIs | % | 1.4 | 1.3 | 105.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 31.2 | 165.9% | |
Shareholders | 130,003 | 151 | 86,094.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | CHANDRA BHAGAT PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.71% | -2.70% | 1.03% |
1-Month | 6.55% | 17.63% | 1.10% |
1-Year | 1.45% | -2.83% | 53.75% |
3-Year CAGR | -12.66% | 27.63% | 14.67% |
5-Year CAGR | 16.39% | 16.65% | 19.26% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the CHANDRA BHAGAT PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of CHANDRA BHAGAT PHARMA the stake stands at 68.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of CHANDRA BHAGAT PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
CHANDRA BHAGAT PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of CHANDRA BHAGAT PHARMA.
For a sector overview, read our pharmaceuticals sector report.
Japan's Nikkei 225 led gains in Asia as markets in the region rose across the board, following Wall Street's continued rally for a second straight day.